GENOVAC
GENOVAC started as a spin-off from the University of Freiburg focussing on the generation of custom-made antibodies and complementary services and has established itself as a leader in the area of antibody generation by genetic immunisation. Innovative proprietary technologies allow the production of highly specific antibodies influencing function directly through immunisation with a cDNA. Conventional immunisation technologies are as well provided. As a customer-oriented service provider GENOVAC helps to guide and advise its clients through intensive interaction, in order to find optimal solutions to their individual needs. GENOVAC has an impressive list of more than 500 international customers and cooperation partners. This list includes renowned national and international research centres as well many global players in the pharmaceutical, biotechnological and agricultural sectors, where GENOVAC is often listed as a preferred vendor.
